Case report · 2025
Conference abstractPublished 31 Jul 2017
Immunosuppression and infection
University of Antwerp, Belgium
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
While chemotherapeutic or immunosuppressive therapies have been considered as the therapeutic cornerstone for several clinical conditions such as cancer, autoimmune diseases and transplant rejection, these drugs are also known to increase the risk of infectious complications. While this is an important safety concern when prescribing immunosuppressive therapies to such patients, several human diseases show a natural immunosuppression that is also linked to a high risk of developing infectious complications. For instance, sepsis is one of the biggest causes of deaths in intensive care units and mortality is associated with both a hyperinflammatory cytokine-mediated disease phase and a protracted innate immune celldriven immunosuppressive phase. Death associated with an immunosuppressive phase in sepsis, similar to HIV patients, is typically due to infectious complications with opportunistic pathogens. Similarly, in stroke patients, while a large proportion of immediate death is due to cerebral infarction and neurological complications, the most common post-stroke complication is that of infection, especially pneumonia, and which is equally responsible for the high morbidity and mortality observed in these patients. We have also recently shown that mechanical ventilation is linked with substantial innate immunosuppression and is likely linked to a high incidence of ventilator-associated pneumonia observed in these patients. This talk will address to mechanisms associated with some of these aetiologies and show how biomarker-directed research aiming to recognize early infections and preventive immune-based strategies could help to minimize the risk of infection and decrease morbidity and mortality in these aetiologies.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Mini review · 11 Jun 2024
Lung Carcinoma-associated Immunosuppression as a Risk Factor for Life-threatening Pulmonary Infections
Perspective · 24 Jun 2022
Infections in the immunosuppressed patients.
Commentary · 27 Dec 2021
Fungal Infections Pathology: Implications for Immunosuppressive Activities
Research article · 19 Mar 2020
Scoparia dulcis protects against Trypanosoma brucei-induced immunosuppression in experimentally infected rabbits
More from this journal
The newest in Journal of Drug Metabolism & Toxicology.
Short communication · 30 Dec 2025
Liver Drug Metabolism Mechanisms Challenges and Future Perspectives
Opinion · 30 Dec 2025
Hepatic metabolism forms the foundation of drug disposition in the human body
Opinion · 30 Dec 2025
Biomarkers of Toxicity for Monitoring Adverse Drug Reactions
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Drug Metabolism & Toxicology
- SubjectDiabetes & Endocrinology
- SubjectPharmaceutical Sciences
- SubjectToxicology
- BylineArticles whose byline prints “Samir Kumar Singh”

